Vascular Architects sold for a pittance
See our story on this San Jose, Calif., medical-device maker, which raised over $42 million but just sold itself for $2.8 million, in today’s daily briefing at VentureBeat Life Sciences.
Next Story: 25 invites for Xobni, cool Outlook app
Previous Story: MAP Pharma prices IPO, aims for $92M haul
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.